Modern stem cell technology is rapidly evolving and holds promise to revolutionize medicine by allowing regeneration of any type of cell within the human body

Blog

  Induced pluripotent stem cells (iPSCs) are a key type of stem cell used for the research of therapeutic uses of stem cells and in drug development. iPSCs have been successfully generated from fibroblasts, embryonic tissues, and blood cells with …

Read On

          Since the advent of modern stem cell biology and the discovery of embryonic stem cells, there has been growing interest in adult stem cells.  First, these cells avoid ethical & religious objections since these cells are not derived from …

Read On

Vitro Biopharma’s CEO, Dr. James Musick was interviewed by Nick Casella, the Senior Life Sciences Analyst of the Wall Street Ledger. An audio link to this interview is attached here. Download Interview Audio The interview includes basic information about the business …

Read On
Stem Cell Treatment for Bone FracturesPosted on February 6, 2013

Fracture healing is a problem that affects an estimated 600,000 people annually in North America [1]. This problem can be caused by diseases such as , brittle bone disease and osteoporosis. Researchers at the University of North Carolina School of …

Read On
Enhanced Wound Healing by MSCsPosted on January 29, 2013

Mesenchymal stem cells (MSCs) have strong tissue regenerative, wound repair and immunomodulatory effects, making cell therapy with MSCs a promising approach to various applications in the field of regenerative medicine. While limited clinical trials have been held in the field …

Read On

Vitro Biopharma recently filed a new patent application for its novel technology of stem cell generation. The new patent includes several procedures to culture adult stem cells known as mesenchymal stem cells (MSCs). Central to the new technology is the …

Read On
Vitro Biopharma

Vitro Biopharma provides basic tools to support stem cell research and clinical development studies including stem cells, cell culture media and measurement tools to assess the functional status of stem cells. We continue to expand our product line to support …

Read On

GOLDEN, Colo., Sept. 12, 2012 (GLOBE NEWSWIRE) – Vitro Diagnostics, Inc. (VODG), dba Vitro Biopharma, announced an agreement with StemGenesis, Inc. (http://www.stemgenesisinc.com) for the exclusive distribution of its products into the following Chinese Provinces: Shanghai, Beijing, Tianjin, Jiangsu, Shandong, Zhejiang, Anhui, Fujian, Hebei, Liaoning …

Read On

GOLDEN, Colo., Aug. 28, 2012 (GLOBE NEWSWIRE) – Vitro Diagnostics, Inc. (VODG), dba Vitro Biopharma, announced advances in the commercialization of its infertility treatment drug, Vitropin(TM), a highly purified form of FSH produced through Vitro Biopharma’s patented production process. During 2011, Vitro licensed two of …

Read On
ISCT shot B

I recently represented Vitro Biopharma at the annual meeting of the International Society of Cellular Therapy in Seattle. Cellular therapy is the process of treating diseases & injury through cell transplantation or the induction of therapeutic cell generation by use of specific …

Read On
US Airways

After much preparation I am now set to go to Seattle to attend the International Society of Cellular Therapy and present a scientific poster session.  I am representing Vitro Biopharma at the meeting and presenting our results generated over the …

Read On